165 filings
DEF 14A
REVB
Revelation Biosciences Inc
Definitive proxy
15 Apr 24
5:33pm
PRE 14A
REVB
Revelation Biosciences Inc
Preliminary proxy
5 Apr 24
4:02pm
8-K
REVB
Revelation Biosciences Inc
22 Mar 24
Results of Operations and Financial Condition
4:22pm
10-K
2023 FY
REVB
Revelation Biosciences Inc
Annual report
22 Mar 24
4:01pm
8-K
REVB
Revelation Biosciences Inc
11 Mar 24
Regulation FD Disclosure
9:53pm
8-K
xzif9ppb6eo5vp
8 Feb 24
Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering
4:01pm
424B3
iolmnn x0l1h
2 Feb 24
Prospectus supplement
4:06pm
EFFECT
wt6rkgs c8
1 Feb 24
Notice of effectiveness
12:15am
8-K
f5v2qxh0ccjis5eb
30 Jan 24
Developing innovative therapeutics to address unmet needs Corporate Presentation / January 2024 www.revbiosciences.com
5:21pm
CORRESP
noh7lxr9uibb4d2fu5x
30 Jan 24
Correspondence with SEC
12:00am
CORRESP
psbrrk2
29 Jan 24
Correspondence with SEC
12:00am
8-K
4qnw9h34
23 Jan 24
Material Modifications to Rights of Security Holders
4:18pm
8-K
jn6y2ovv
22 Jan 24
Submission of Matters to a Vote of Security Holders
4:01pm
UPLOAD
a3pw3t in3yto5o7
2 Jan 24
Letter from SEC
12:00am
8-K
ujnlc 9x1
13 Nov 23
Results of Operations and Financial Condition
4:30pm